Literature DB >> 7026600

Serotyping Cryptococcus neoformans by immunofluorescence.

W Kaplan, S L Bragg, S Crane, D G Ahearn.   

Abstract

Four serotypes of Cryptococcus neoformans designated A, B, C, and D are currently recognized. Although an agglutination test is most often used to serotype C. neoformans in cultures, this test is not appropriate for typing the fungus in fixed tissues. A study to prepare fluorescent-antibody reagents for typing C. neoformans in cultures and to determine whether they can be used to type this fungus in fixed tissues was carried out. Antisera to one strain belonging to each of the four serotypes were prepared in rabbits by intravenous injection of whole Formalin-killed cryptococci. Each antiserum was labeled with fluorescein isothiocyanate and then adsorbed with cells of each of the heterologous serotypes. The adsorbed conjugates were then tested against six serotype A isolates and five isolates of each of the other three serotypes. Labeled serotype A or D antiserum adsorbed with either B or C cells stained the A and D, but not the B or C, isolates. Labeled serotype B antiserum adsorbed with A cells stained the B and C, but not the A or D, isolates. Labeled A antiserum absorbed with D cells differentiated A from D; labeled C antiserum absorbed with B cells differentiated C from B. Of the 21 test isolates, 17 could be serotyped in paraffin sections of tissues of experimentally infected mice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026600      PMCID: PMC271960          DOI: 10.1128/jcm.14.3.313-317.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Fluorescent antibody staining of Sporotrichum schenckii in cultures and clinical materials.

Authors:  W KAPLAN; M S IVENS
Journal:  J Invest Dermatol       Date:  1960-09       Impact factor: 8.551

2.  Staining bacterial smears with fluorescent antibody. I. General methods for Malleomyces pseudomallei.

Authors:  M GOLDMAN; M D MOODY; B M THOMASON
Journal:  J Bacteriol       Date:  1956-09       Impact factor: 3.490

3.  A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica).

Authors:  J M NEILL; I ABRAHAMS; C E KAPROS
Journal:  J Bacteriol       Date:  1950-02       Impact factor: 3.490

4.  Capsule size of Cryptococcus neoformans: control and relationship to virulence.

Authors:  M A Dykstra; L Friedman; J W Murphy
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Demonstration of pathogenic fungi in formalin-fixed tissues by immunofluorescence.

Authors:  W Kaplan; D E Kraft
Journal:  Am J Clin Pathol       Date:  1969-10       Impact factor: 2.493

6.  Serologic grouping of Cryptococcus neoformans.

Authors:  D E Wilson; J E Bennett; J W Bailey
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

7.  Epidemiologic differences among serotypes of Cryptococcus neoformans.

Authors:  J E Bennett; K J Kwon-Chung; D H Howard
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

8.  Fluorescent-antibody reagent for the identification of Cryptococcus neoformans.

Authors:  V Pidcoe; L Kaufman
Journal:  Appl Microbiol       Date:  1968-02

9.  Cryptococcus neoformans serotype groups encountered in Oklahoma.

Authors:  H G Muchmore; E N Scott; F G Felton; R A Fromtling
Journal:  Am J Epidemiol       Date:  1980-07       Impact factor: 4.897

10.  Staining toxoplasma gondii with fluorescein-labelled antibody. II. A new serologic test for antibodies to Toxoplasma based upon inhibition of specific staining.

Authors:  M GOLDMAN
Journal:  J Exp Med       Date:  1957-06-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Immunohistologic diagnosis of systemic mycoses: an update.

Authors:  L Kaufman
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Disseminated infection caused by urease-negative Cryptococcus neoformans.

Authors:  P J Ruane; L J Walker; W L George
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

3.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.

Authors:  F Dromer; E Gueho; O Ronin; B Dupont
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Multilocus enzyme typing of Cryptococcus neoformans.

Authors:  M E Brandt; S L Bragg; R W Pinner
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

6.  Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryplococcal Disease Active Surveillance Group.

Authors:  M E Brandt; L C Hutwagner; R J Kuykendall; R W Pinner
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.